VANGUARD GROUP INC - SANA BIOTECHNOLOGY INC ownership

SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 117 filers reported holding SANA BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of SANA BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2024$70,317,594
-42.2%
12,878,680
+6.0%
0.00%
-50.0%
Q1 2024$121,551,730
+204.1%
12,155,173
+24.1%
0.00%
+100.0%
Q4 2023$39,972,103
+12.7%
9,797,084
+6.9%
0.00%0.0%
Q3 2023$35,478,554
-34.3%
9,167,585
+1.2%
0.00%0.0%
Q2 2023$54,000,092
+81.8%
9,060,418
-0.3%
0.00%0.0%
Q1 2023$29,710,997
-16.1%
9,085,932
+1.3%
0.00%0.0%
Q4 2022$35,418,208
-33.2%
8,966,635
+1.4%
0.00%
-50.0%
Q3 2022$53,040,000
+2.4%
8,839,881
+9.8%
0.00%
+100.0%
Q2 2022$51,777,000
-18.3%
8,052,411
+5.0%
0.00%0.0%
Q1 2022$63,351,000
-46.9%
7,669,682
-0.5%
0.00%
-66.7%
Q4 2021$119,322,000
-30.2%
7,708,151
+1.6%
0.00%
-25.0%
Q3 2021$170,895,000
+253.2%
7,588,544
+208.3%
0.00%
+300.0%
Q2 2021$48,387,000
-37.9%
2,461,181
+5.7%
0.00%
-50.0%
Q1 2021$77,906,0002,327,6070.00%
Other shareholders
SANA BIOTECHNOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Trustees of Columbia University in the City of New York 281,250$6,334,0009.69%
Flagship Pioneering Inc. 34,239,018$771,063,0008.08%
Crestline Management, LP 3,210,937$72,310,0006.80%
SB Management Ltd 2,209,004$49,747,0005.10%
Omega Fund Management, LLC 843,750$19,001,0002.13%
HARVARD MANAGEMENT CO INC 1,163,601$26,204,0001.54%
Alphabet Inc. 2,812,500$63,338,0001.50%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 387,508$8,727,0001.03%
PUBLIC SECTOR PENSION INVESTMENT BOARD 4,131,249$93,036,0000.53%
Dragoneer Investment Group 1,500,000$33,780,0000.44%
View complete list of SANA BIOTECHNOLOGY INC shareholders